Pluristem Therapeutics Inc

NASDAQ:PSTI   3:25:39 PM EDT
9.40
-0.47 (-4.76%)
Products, Regulatory

Pluristem Expands Its Phase II Covid-19 European Clinical Trial To Israel

Published: 10/07/2020 06:17 GMT
Pluristem Therapeutics Inc (PSTI) - Pluristem Expands Its Phase Ii Covid-19 European Clinical Trial to Israel.
Pluristem Therapeutics - Approval From Israeli Ministry of Health to Commence Patient Enrollment in Israel for Co's Covid-19 Phase Ii Clinical Trial.
Pluristem Therapeutics -40 Patients Hospitalized With Severe Covid-19 Complicated by Ards Will Be Enrolled at Clinical Sites in Israel and Germany.